Cargando…

System of adverse drug reactions reporting: What, where, how, and whom to report?

Detalles Bibliográficos
Autores principales:	Kalaiselvan, Vivekanandan, Kumar, Pranay, Mishra, Prabhakar, Singh, Gyanendra Nath
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578206/ https://www.ncbi.nlm.nih.gov/pubmed/26430348 http://dx.doi.org/10.4103/0972-5229.164819

Ejemplares similares

Adverse drug reactions due to ophthalmic drugs: Reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Adverse drug reactions reporting culture in Pharmacovigilance Programme of India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2014)

“ADR PvPI” Android mobile app: Report adverse drug reaction at any time anywhere in India
por: Prakash, Jai, et al.
Publicado: (2019)

Pharmacovigilance in drugs used in the treatment of drug dependence
por: Thota, Anusha, et al.
Publicado: (2017)

Implementation of adverse event reporting for medical devices, India
por: Shukla, Shatrunajay, et al.
Publicado: (2020)

Pharmacovigilance Programme of India: Recent developments and future perspectives
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2016)

Intraocular devices associated adverse events reporting system in India
por: Kalaiselvan, Vivekanandan, et al.
Publicado: (2020)

Midwifery continuity of care: A scoping review of where, how, by whom and for whom?
por: Bradford, Billie F., et al.
Publicado: (2022)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database
por: Rastogi, Shruti, et al.
Publicado: (2022)

Incident Reporting of Adverse Drug Reaction to Intravenous Ranitidine in an Emergency Department
por: Sud, Saurabh, et al.
Publicado: (2018)

How to improve regulatory practices for refurbished medical devices
por: Shukla, Shatrunajay, et al.
Publicado: (2023)

Exploring the context of sedentary behaviour in older adults (what, where, why, when and with whom)
por: Leask, Calum F., et al.
Publicado: (2015)

Proposal for Publishing and Parallel Reporting of Case Reports on Adverse Drug Reactions to Authorities by Physicians
por: Sickmüller, Barbara, et al.
Publicado: (2013)

Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023)

Letter to the editor—a need to strengthen the adverse drug reaction reporting during COVID-19
por: Bakshi, Satvinder Singh, et al.
Publicado: (2021)

Oncoplastic Breast Surgery: What, When and for Whom?
por: Macmillan, R. Douglas, et al.
Publicado: (2016)

Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education
por: Khan, Zakir, et al.
Publicado: (2020)

Adverse drug reactions of itolizumab in COVID-19 patient: A case report
por: Mohammed, Ziauddin, et al.
Publicado: (2022)

Psychotherapy belongs to whom?
por: Linganna, Siddeswara Bargur, et al.
Publicado: (2020)

Veterinary pharmacovigilance in India: A need of hour
por: Kumar, Rishi, et al.
Publicado: (2017)

Adverse cutaneous drug reactions
por: Adibi, Neda
Publicado: (2014)

Development of phimosis as an adverse drug reaction to capecitabine with irinotecan
por: Patel, Priyeshkumar, et al.
Publicado: (2022)

Person‐centred care in primary care: What works for whom, how and in what circumstances?
por: Ahmed, Anam, et al.
Publicado: (2022)

Itraconazole in chronic pulmonary aspergillosis: In whom, for how long, and at what dose?
por: Maturu, Venkata Nagarjuna, et al.
Publicado: (2015)

Discouraging adverse drug reactions reporting culture: Just a tip of the ‘Gullible Prescribing’
por: Mohammed, Imran
Publicado: (2013)

Safety monitoring of local anaesthetic drugs from the perspective of Pharmacovigilance Programme of India
por: Kumar, Pramod, et al.
Publicado: (2017)

The ‘What, Why, Where and How’ of Delivering a Drug
por: Mukherjee, Kusumika
Publicado: (2020)

Pattern of adverse drug reactions reported by the community pharmacists in Nepal
por: Palaian, Subish, et al.
Publicado: (2010)

Tracking family medicine graduates. Where do they go, what services do they provide and whom do they see?
por: Jaakkimainen, R Liisa, et al.
Publicado: (2012)

Under-Reporting of Adverse Drug Reactions in Finland and Healthcare Professionals’ Perspectives on How to Improve Reporting
por: Sandberg, Andreas, et al.
Publicado: (2022)

Status of documentation grading and completeness score for Indian individual case safety reports
por: Vivekanandan, Kalaiselvan, et al.
Publicado: (2015)

Increasing adverse drug reaction reporting—How can we do better?
por: Potlog Shchory, Miri, et al.
Publicado: (2020)

First reports of adverse drug reactions
Publicado: (2022)

First reports of adverse drug reactions
Publicado: (2022)

The Dentists—Kentucky State Dental Association—How It Was Organized, by Whom, and for What Purpose
Publicado: (1872)

Access to What for Whom? How Care Delivery Innovations Impact Health Equity
por: Szymczak, Julia E., et al.
Publicado: (2023)

Mobile Exergaming in Adolescents’ Everyday Life—Contextual Design of Where, When, with Whom, and How: The SmartLife Case
por: Schwarz, Ayla, et al.
Publicado: (2018)

Desogestrel and panic attacks – a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports
por: Watson, Sarah, et al.
Publicado: (2018)

Unravelling the Effects of the Healthy Primary School of the Future: For Whom and Where Is It Effective?
por: Bartelink, Nina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a3nrdmpkl04i8abvkt5iecst3l